REG - BSF Enterprise PLC - Admission of Shares

BSF EnterpriseAnnouncement

Today 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260417:nRSQ9267Aa&default-theme=true

RNS Number : 9267A  BSF Enterprise PLC  17 April 2026

17 April 2026

 

BSF Enterprise PLC

Admission of Placing Shares

Further to the announcement published on 02 April 2026, BSF Enterprise PLC
("BSF" or the "Company"), a leading innovator in tissue-engineered materials,
announces that 38,500,000 ordinary shares of £0.01 each in the issued share
capital of the Company ("April 2026 Placing Shares") have been admitted
yesterday, 16 April 2026, to trading on the Main Market of the London Stock
Exchange.

 

April 2025 Placing - admission update

Further to the announcement published on 28 April 2025 in relation to the
placing of 4,725,000 new ordinary shares in the Company at 3 pence per share
(the "April 2025 Placing Shares"), the Company has instructed new advisers,
Bowsprit Partners, to arrange the application for the April 2025 Placing
Shares to be admitted to listing on the Official List and to trading on the
Main Market of the London Stock Exchange ("Admission").

The April 2025 Placing Shares were issued on 15 May 2025 pursuant to the
placing announced on 28 April 2025. It is expected that Admission will become
effective and that dealings in those shares are expected to commence at 8.00
a.m. on 21 April 2026.

Correction to Broker Warrants disclosure

The Company corrects an error in its announcement of 2 April 2026. The number
of Broker Warrants was stated as 23,100. The correct number is 2,310,000.

Total voting rights

Following Admission, the total number of ordinary shares and voting rights in
the Company will be 166,874,437. The total number of ordinary shares in issue
is unchanged from the announcement dated 2 April 2026, as the April 2025
Placing Shares were already issued and included in that figure.

This figure may be used by shareholders in the Company as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of
Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market
Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

END

Engage with the BSF Enterprise management team directly by asking questions,
watching video summaries and seeing what other shareholders have to say.
Navigate to our Interactive Investor website here:

 https://bsfenterprise.com/link/y0zqZr

 For further enquiries, please visit www.bsfenterprise.com
(http://www.bsfenterprise.com/)  or contact:

 BSF Enterprise PLC                                                           https://bsfenterprise.com/s/a1f22b (https://bsfenterprise.com/s/a1f22b)

 Geoff Baker - Chairman

 Che Connon - CEO & Director

 We encourage all investors to share questions on this announcement via our
 investor website.
 Bowsprit Partners

 John Treacy                                                                   +44 (0)203 883 4430

 James Sheehan
 Shard Capital (Broker)

 Damon Heath                                                                  (0)20 4530 6926

 Isabella Pierre                                                              (0)20 4530 6928
 ISIN of the Ordinary Shares

 is GB00BHNBDQ51.

 SEDOL Code is BHNBDQ5.

 

 

 

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
(https://bsfenterprise.com/s/bb9f43)

About BSF Enterprise PLC

BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge
tissue-engineered solutions, including lab-grown leather (via LGL), cultivated
meat, and corneal repair technologies. By leveraging its proprietary
scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance
alternatives to conventional materials, targeting global markets where
provenance, ethics, and performance are increasingly prized by consumers and
brands alike.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGMDNNDGVZG



            Copyright 2019 Regulatory News Service, all rights reserved